This is an important property of PR1A3, given the finding that soluble CEA can accumulate in lymph nodes and lead to false positive detection of cancers in lymph nodes when using other anti-CEA antibodies for immunoscintigraphy (Granowska et al, 1989). The gene discussed is CEACAM5; the disease is cancer.